InvestorsHub Logo
Followers 281
Posts 33618
Boards Moderated 1
Alias Born 11/14/2013

Re: longusa post# 24028

Wednesday, 11/19/2014 10:44:17 AM

Wednesday, November 19, 2014 10:44:17 AM

Post# of 725790
Yes, you are correct. And as Pyrr pointed out, if CLDX does obtain early approval and market entry, it constitute yet another trailblazer widening the path for DCVax. I see this as a win-win. Ultimately, CLDX EGFRvIII tech may be absorbed by licensing, merger or sale -- because it is limited; but for now, it will benefit from early entry.


Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News